20187-55-7
20187-55-7
Chemical Structure
Bendazac
- CAS No.: 20187-55-7
- Formula:C16H14N2O3
- Molecular Weight:282.29
IUPAC Name: 2-((1-benzyl-1H-indazol-3-yl)oxy)acetic acid
InChIKey: BYFMCKSPFYVMOU-UHFFFAOYSA-N
SMILES: O=C(O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
Biological Activity: Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation and delays the cataractogenic process[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bendazac | 99.43% | Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation and delays the cataractogenic process. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bendazac (Standard) | ≥98% | Bendazac (Standard) is the analytical standard of Bendazac. This product is intended for research and analytical applications. Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation and delays the cataractogenic process. Bendazac exerts funciton in anti-radical effect and inhibits oxidative brust. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.81
HY-30235Benzydamine -
Similarity Score 0.81
HY-30235ARBenzydamine hydrochloride (Standard) -
Similarity Score 0.79
HY-B2165Bendazac L-Lysine -
Similarity Score 0.79
HY-N11425Benzydamine N-Oxide -
Similarity Score 0.79
HY-141780SDemethyl Benzydamine-d3 hydrochloride -
Similarity Score 0.74
HY-30235SBenzydamine-d6 hydrochloride -
Similarity Score 0.73
HY-141773SBenzydamine N-oxide-d6 -
Similarity Score 0.66
HY-W3543691-(4-Fluorobenzyl)-1H-indazole-3-carboxylic acid -
Similarity Score 0.62
HY-N101591-Benzyl-I3C -
Explore the MedChemAI to find more analogs
References
- [1]. Balfour JA, et al. Bendazac lysine. A review of its pharmacological properties and therapeutic potential in the management of cataracts. Drugs. 1990;39(4):575-596. [Content Brief]
- [2]. Guglielmotti A, et al. Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agent. Pharmacol Res. 1995;32(6):369-373. [Content Brief]
